Franziska Bott

Title: Franziska Bott: Innovator in Antibody Constructs

Introduction

Franziska Bott is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibody constructs. Her work focuses on innovative solutions for targeting specific cells in medical applications.

Latest Patents

Franziska Bott holds a patent for "Antibody constructs for FLT3 and CD3." This invention relates to a bispecific antibody construct that includes a first binding domain targeting human FLT3 on the surface of a target cell and a second binding domain that binds to human CD3 on the surface of a T cell. The patent also encompasses a polynucleotide encoding the antibody construct, a vector containing the polynucleotide, and a host cell transformed or transfected with the polynucleotide or vector. Additionally, the invention outlines a process for producing the antibody construct, its medical uses, and a kit that includes the antibody construct. She has 1 patent to her name.

Career Highlights

Franziska Bott has worked with prominent companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Amgen Research GmbH. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Franziska has collaborated with notable colleagues such as Tobias Raum and Claudia Blümel. These partnerships have enhanced her research and development efforts, leading to innovative advancements in antibody technology.

Conclusion

Franziska Bott's contributions to the field of biotechnology, particularly through her patent on bispecific antibody constructs, highlight her role as an influential inventor. Her work continues to pave the way for advancements in targeted therapies.